Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-01-27 @ 12:01 PM
Study NCT ID:
NCT01076192
Status:
COMPLETED
Last Update Posted:
2016-01-06
First Post:
2010-02-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Moderate-to-severe Chronic Plaque Psoriasis | View |